Purchase
Description
Panitumumab biosimilar is a recombinant, human IgG2 kappa monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). It has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.
Panitumumab biosimilar is supplied at a concentration of 20 mg/mL as a sterile, colorless liquid of pH 5.6 to 6.0, which contains 5.8 mg/mL sodium chloride, 6.8 mg/mL sodium acetate.
Statement: this product is used for R&D only, not for clinical usage.
Properties
|
Name
|
Panitumumab biosimilar
|
|
CAS
NO.
|
339177-26-3
|
|
Type
|
Whole
antibody
|
|
Source
|
Human
|
|
Target
|
EGF receptor
|
|
Clone
|
Monoclone
|
|
Formula
|
C6398H9878N1694O2016S48
|
|
Molecular
Weight
|
147 kDa
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Storage
|
-70±15℃ for long-term storage,
2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508154712061206.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Panitumumab
|
